Kragerø Tablettproduksjon

Kragerø Tablettproduksjon is a specialized contract development and manufacturing organization (CDMO) based in Norway, focusing on solid dosage forms and liquid pharmaceuticals. The company offers comprehensive manufacturing services including granulation, compression, film coating, and automated packaging for both prescription and over-the-counter medicines. Originally the manufacturing arm of the Norwegian pharmaceutical firm Weifa, the facility has decades of experience in high-volume production. In 2022, it was acquired by Curida, a leading Nordic CDMO, to expand its capacity in solid oral dosage forms. The site operates under European GMP standards and serves a diverse portfolio of international pharmaceutical clients.